Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry

INTRODUCTION: Apixaban has been shown to be superior to warfarin in patients with non-valvular atrial fibrillation in the randomized ARISTOTLE trial and its use is recommended in current guidelines. There are only scarce data about its use, efficacy, and safety in unselected patients in Germany. MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiol Ther
Main Authors: Zeymer, Uwe, Lober, Christiane, Wolf, Andreas, Richard, Frank, Schäfer, Heinrich, Taggeselle, Jens, Kabitz, Hans-Joachim, Prondzinsky, Roland, Süselbeck, Tim
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7584711/
https://ncbi.nlm.nih.gov/pubmed/32638266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40119-020-00188-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados